- Protocol Short Name and Number: URD PB vs B, 0201
- Protocol Long Name: A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors
- Protocol (PDF)
- Informed Consents Forms
- Key Personnel
- BMT CTN # 0201 Protocol Chair: Claudio Anasetti, MD
- BMT CTN # 0201 Protocol Officer: Dennis Confer, MD
- BMT CTN # 0201 Medical Monitor: Chris Bredeson, MD
- ADD BMT CTN # 0201 Protocol Coordinator: bmtctn@emmes.com
- Keywords: Unrelated, Unrelated Donor, Allogeneic Transplant, Allo Transplant, Allo, PBSC, Peripheral Blood Stem Cell, Bone Marrow, Pediatric, Leukemia, Myelodysplastic Syndrome, MDS, Myeloproliferative Disorders, Quality of Life, QOL, Child, Children, Teen, Adolescent
The BMT CTN #0201 study met its target accrual of 550 patients and closed enrollment on September 9, 2009.